Condition: Influenza · COVID-19 · SARS-COV-2 Infection · Sponsor: Boston University
This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and tertiary care and the obstetric department delivers about 10,000 babies a year. The hypothesis is that co-infection of other respiratory viruses (ORV), particularly COVID-19 and Influenza increases the risk of adverse pregnancy outcomes in mothers and babies and could address the current standard of care in India to not vaccinate pregnant women during pregnancy, by either encouraging vaccination against both viruses before planning a pregnancy or during pregnancy based on global data supporting the safety of this strategy.
This description comes directly from the study's public registry record.
Patricia Hibberd, MD PhD · 617-358-2046 · plh0@bu.edu
Aboli Goghari, MPH · 617-358-2310 · agoghari@bu.edu
Always discuss trial participation with your own doctor first.
| Boston University School of Public Health, Global Health | Boston, Massachusetts, United States | Recruiting |
| Government. Medical College Hospital | Nagpur, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06168019